Venture Creation is in Vogue

In the biotech industry, it’s common for a company to raise billions of dollars and wait more than a dozen years before their investors see a return. That’s why capital formation can be an arduous journey in the biotech industry.
But the biotech IPO market is coming off of a hot 2018 with more than 50 biotech companies going public on the back of more than $5.4 billion in funding, marking the second-best year for biotech IPOs in a decade. But what challenges will need to be overcome